Xpeditemd, Inc.
XpediteMD is a U.S.-based, founder-led SaaS company that sells an AI-powered cloud platform for oncology patient navigation, ambient encounter documentation, and billable navigation revenue capture to oncology practices, health plans, and medical groups.
- Company typePrivate
- Founded2021
- HeadquartersTorrance, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Xpeditemd, Inc. does
XpediteMD, Inc. is a privately held, founder-led digital health company headquartered in Torrance, California, that has built an AI-powered cloud-based SaaS platform for oncology care navigation, clinical decision support, and billing enablement. The company sells primarily to U.S. oncology practices, health plans, and multi-provider medical groups, with a flagship partnership with SilverSummit Healthplan on breast cancer navigation (Project Accelerate).
The platform is organized around two product modules. XpediteMD Navigate™ is a unified patient navigation suite that ambiently captures navigation encounters via AI, tracks consents and clinical and social risk factors (including SDoH), and automatically maps encounters to oncology-specific CPT and HCPCS codes (PCM, PIN, CHI) based on navigator credentials to generate compliant billing documentation. XpediteMD Accelerate™ is a clinical decision support module for hospital systems and health plans that pre-qualifies guideline-based treatment pathways by cancer type and tumor characteristics, reducing prior authorization friction. The company markets outcomes including 77% reduction in biopsy-to-treatment time, 67% reduction in unnecessary prior authorizations, 95%+ guideline-compliant care, and $50,000+ in annual navigation revenue per provider.
XpediteMD operates as a SaaS subscription business with a direct enterprise field sales motion complemented by inside-sales demo capture, conference presence at ASBrS, ASTRO, and ACS Clinical Congress, an educational webinar program, and content marketing including a Navigation Revenue Calculator and billing guides. Pricing for the core navigation platform is sold via demo and is quote-based for enterprise contracts; the publicly listed Basic ($0), Pro ($199/month), and Enterprise ($399/month) tiers appear on the company website but reference an internal HR-management product rather than the navigation platform. The company is HIPAA compliant and PCI-DSS compliant via its payment processor, was founded in 2021 by Dennis R. Holmes, MD, FACS (Co-founder, CEO & CPO) and Artem Petrov (Head of Product), operates with 1–10 employees, and has no disclosed external institutional funding or parent company.
Xpeditemd, Inc. firmographics
Firmographics- Name
- Xpeditemd, Inc.
- Legal name
- XpediteMD Inc.
- Website
- https://xpeditemd.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- XpediteMD is a U.S.-based, founder-led SaaS company that sells an AI-powered cloud platform for oncology patient navigation, ambient encounter documentation, and billable navigation revenue capture to oncology practices, health plans, and medical groups.
- Ownership category
- akta.pro rank
Xpeditemd, Inc. industry classification
Industry- Product category
- Oncology Patient Navigation Software
- NAICS
- Software Publishers (5132), Computer Systems Design and Related Services (5415)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
- akta.pro secondary industries
- Oncology Telemedicine Platforms (HLALAGAH), Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling) (HLACAPAM), Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)
Keywords
Where Xpeditemd, Inc. is headquartered
LocationHeadquarters
- HQ city
- Torrance
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Xpeditemd, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscription: XpediteMD operates as a Software-as-a-Service platform offered at tiered pricing plans (Basic, Pro, Enterprise). The platform is offered as a cloud-based, integratable digital navigation and oncology care platform. Pricing is per user tier with up to 5 users (Free), 20 users ($199/month), or 50 users ($399/month).
- Navigation Billing Revenue Generation: The platform helps oncology practices generate revenue by enabling them to bill for patient navigation services using new CPT and HCPCS codes (PCM, PIN, CHI, SDOH). The company positions this as turning navigation from a cost center into a revenue stream, generating $50,000+ in annual revenue per provider for work already being performed.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free plan for up to 5 users - basic features |
| Subscription | Monthly | Pro plan for up to 20 users |
| Subscription | Monthly | Enterprise plan for up to 50 users |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Xpeditemd, Inc. product offering
Product offeringCore offering
XpediteMD provides an AI-powered, cloud-based SaaS platform that enables oncology practices to deliver patient navigation services. The platform combines ambient scribing of clinical encounters with oncology-specific clinical decision support and automated CPT/HCPCS code mapping so that navigation time and activities can be documented and billed under CMS and commercial-payer rules. The platform is sold as two suites — Navigate (patient navigation product suite) and Accelerate (clinical decision support module).
Product overview
XpediteMD is an AI-powered oncology navigation platform offered as a cloud-based SaaS solution with two main product modules: XpediteMD Navigate™ (patient navigation product suite) and XpediteMD Accelerate™ (clinical decision support for health plans). The platform is designed for oncology practices, health plans, and medical groups. Navigate handles end-to-end patient navigation including encounter capture, documentation, and billing analytics, while Accelerate provides clinical decision support and order management for larger systems. The company also offers tiered pricing plans (Basic free, Pro at $199/month, Enterprise at $399/month) for different organization sizes.
Differentiator
Problem solved
Functional benefit
Brands
- XpediteMD Navigate™: AI-powered patient navigation product suite that organizes cancer navigation workflows, captures encounters in real time, and generates billing documentation.
- XpediteMD Accelerate™
Products and services
- XpediteMD Navigate™
- XpediteMD Accelerate™
Quantifiable outcome
- 77% reduction in biopsy-to-treatment time
- +7 more outcomes
Companies that use Xpeditemd, Inc.
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Xpeditemd, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature8 records
Xpeditemd, Inc. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SilverSummit HealthplancoreBreast cancer navigation initiative (Project Accelerate) demonstrating measurable reductions in time to treatment after implementing XpediteMD navigation workflows. SilverSummit Healthplan publicly praised the collaboration, noting how XpediteMD helps breast cancer patients obtain care faster. The partnership has generated published outcomes and real-world evidence of platform effectiveness.
Scale indicators8 records
Recent moves5 records
Expansion highlights5 records
Xpeditemd, Inc. competitors and assessment
Company assessmentDirect peers
- Canopy: Oncology care management platform providing care navigation, symptom tracking, and nurse triage for community oncology. Comparable in patient navigation workflow automation and oncology-specific clinical decision support.
- Carevive: Oncology care management and patient-reported outcomes platform serving cancer practices and life sciences. Directly comparable in oncology patient navigation, symptom monitoring, and care plan delivery.
- Navigating Cancer: Oncology-focused patient engagement and care navigation platform used by community oncology practices. Closest direct competitor, offering patient navigation, triage, and care plan tools overlapping directly with XpediteMD Navigate.
Emerging players
- Jvion: AI-driven clinical decision support and patient risk analytics platform across multiple conditions including oncology. Overlaps with XpediteMD Accelerate's guideline-based decision support capabilities.
Broad incumbents
- NantHealth: Oncology-focused clinical decision support and care coordination platform offering evidence-based treatment pathways. Comparable in guideline-concordant care delivery and navigation; broader portfolio than XpediteMD.
- Flatiron Health: Oncology-specific EHR and real-world data platform used by community oncology practices. Broader incumbent with practice-management depth and embedded decision support overlapping with XpediteMD's provider-facing modules.
- Tempus Labs: AI-enabled precision oncology platform combining clinical data, molecular profiling, and decision support. Larger, broader incumbent with adjacent oncology decision support but focused on molecular/therapeutic selection rather than navigation workflow.
- Elekta: Radiation therapy and oncology informatics provider offering treatment planning, software, and services. Adjacent incumbent in oncology clinical workflow and decision support across hospital systems.
- McKesson (US Oncology Network): Oncology services and distribution giant that acquired Navigating Cancer and operates US Oncology Network. Sets the bar for incumbent oncology care management and navigation deployment at scale.
- Varian (Siemens Healthineers): Radiation oncology treatment planning and oncology workflow software incumbent (now part of Siemens Healthineers). Large incumbent addressing oncology care delivery and treatment pathways at hospital systems.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Xpeditemd, Inc. social profiles
Digital presenceXpeditemd, Inc. compliance and trust
Trust signalCompliance2 records
Xpeditemd, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xpeditemd, Inc. leadership team
Management profileNumber of profiles
Profiles3 records
Xpeditemd, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xpeditemd, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xpeditemd, Inc.
What does Xpeditemd, Inc. do?
XpediteMD provides an AI-powered, cloud-based SaaS platform that enables oncology practices to deliver patient navigation services. The platform combines ambient scribing of clinical encounters with oncology-specific clinical decision support and automated CPT/HCPCS code mapping so that navigation time and activities can be documented and billed under CMS and commercial-payer rules. The platform is sold as two suites — Navigate (patient navigation product suite) and Accelerate (clinical decision support module).
Is Xpeditemd, Inc. a public or private company?
Xpeditemd, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Xpeditemd, Inc. founded?
Xpeditemd, Inc. was founded in 2021. It employs 1 to 10 people.
Where is Xpeditemd, Inc. based?
Xpeditemd, Inc. is headquartered in Torrance, United States, in the North America region.
How does Xpeditemd, Inc. make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are navigation Billing Revenue Generation.
Who are Xpeditemd, Inc.'s main competitors?
Direct peers on record are Canopy, Carevive and Navigating Cancer. Jvion is listed as an emerging player. Broad incumbents are NantHealth, Flatiron Health, Tempus Labs, Elekta, McKesson (US Oncology Network) and Varian (Siemens Healthineers).
Does Xpeditemd, Inc. have an API?
No public API is recorded for Xpeditemd, Inc..
What industry is Xpeditemd, Inc. in?
Xpeditemd, Inc.'s product category is Oncology Patient Navigation Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 5132 and its SIC code is 8000.